M. Brian Arnold

1.3k total citations
29 papers, 1.1k citations indexed

About

M. Brian Arnold is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, M. Brian Arnold has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Organic Chemistry and 14 papers in Cellular and Molecular Neuroscience. Recurrent topics in M. Brian Arnold's work include Neuroscience and Neuropharmacology Research (13 papers), Phenothiazines and Benzothiazines Synthesis and Activities (6 papers) and Receptor Mechanisms and Signaling (6 papers). M. Brian Arnold is often cited by papers focused on Neuroscience and Neuropharmacology Research (13 papers), Phenothiazines and Benzothiazines Synthesis and Activities (6 papers) and Receptor Mechanisms and Signaling (6 papers). M. Brian Arnold collaborates with scholars based in United States and Switzerland. M. Brian Arnold's co-authors include Paul L. Ornstein, Rebecca A. Wright, Darryle D. Schoepp, William J. Wheeler, David Lodge, J. David Leander, D D Schoepp, Thomas J. Bleisch, Jonathan W. Paschal and Dennis M. Zimmerman and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and The Journal of Organic Chemistry.

In The Last Decade

M. Brian Arnold

26 papers receiving 990 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Brian Arnold United States 18 596 579 413 98 70 29 1.1k
Eric Vieira Switzerland 18 825 1.4× 542 0.9× 430 1.0× 49 0.5× 99 1.4× 25 1.4k
Günter Neef Germany 18 635 1.1× 400 0.7× 472 1.1× 67 0.7× 86 1.2× 71 1.4k
David D. Wisnoski United States 17 805 1.4× 565 1.0× 789 1.9× 64 0.7× 81 1.2× 26 1.7k
Fabrizio Micheli Italy 21 645 1.1× 423 0.7× 582 1.4× 78 0.8× 33 0.5× 68 1.2k
Andrew Thurkauf United States 23 998 1.7× 943 1.6× 415 1.0× 53 0.5× 73 1.0× 61 1.6k
B. L. CHENARD United States 20 591 1.0× 516 0.9× 957 2.3× 107 1.1× 60 0.9× 30 1.6k
Kevin J. Merchant United States 18 599 1.0× 454 0.8× 509 1.2× 53 0.5× 40 0.6× 30 1.3k
Romano Di Fabio Italy 24 609 1.0× 336 0.6× 900 2.2× 85 0.9× 117 1.7× 104 1.7k
Edwin J. Schweiger United States 12 438 0.7× 391 0.7× 571 1.4× 41 0.4× 40 0.6× 14 1.0k
Dianne Kowal United States 21 713 1.2× 466 0.8× 347 0.8× 67 0.7× 71 1.0× 39 1.3k

Countries citing papers authored by M. Brian Arnold

Since Specialization
Citations

This map shows the geographic impact of M. Brian Arnold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Brian Arnold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Brian Arnold more than expected).

Fields of papers citing papers by M. Brian Arnold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Brian Arnold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Brian Arnold. The network helps show where M. Brian Arnold may publish in the future.

Co-authorship network of co-authors of M. Brian Arnold

This figure shows the co-authorship network connecting the top 25 collaborators of M. Brian Arnold. A scholar is included among the top collaborators of M. Brian Arnold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Brian Arnold. M. Brian Arnold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arnold, M. Brian, et al.. (2025). LEVA: A High-Mobility Logistic Vehicle with Legged Suspension. Zürcher Hochschule für Angewandte Wissenschaften digital collection (Zurich University of Applied Sciences). 7438–7444.
2.
Ornstein, Paul L., Dennis M. Zimmerman, M. Brian Arnold, et al.. (2000). Biarylpropylsulfonamides as Novel, Potent Potentiators of 2-Amino-3- (5-methyl-3-hydroxyisoxazol-4-yl)- propanoic Acid (AMPA) Receptors. Journal of Medicinal Chemistry. 43(23). 4354–4358. 62 indexed citations
3.
Wright, Rebecca A., M. Brian Arnold, William J. Wheeler, Paul L. Ornstein, & Darryle D. Schoepp. (2000). Binding of [ 3 H](2 S ,1' S ,2' S )-2-(9-xanthylmethyl)-2-(2'-carboxycyclopropyl)glycine ([ 3 H]LY341495) to cell membranes expressing recombinant human group III metabotropic glutamate receptor subtypes. Naunyn-Schmiedeberg s Archives of Pharmacology. 362(6). 546–554. 48 indexed citations
4.
5.
Ornstein, Paul L., et al.. (1998). Heteroatom-substitution as a strategy for increasing the potency of competitive NMDA antagonists. Bioorganic & Medicinal Chemistry Letters. 8(4). 389–394. 16 indexed citations
6.
Ornstein, Paul L., et al.. (1998). [3H]LY341495, a highly potent, selective and novel radioligand for labeling group II metabotropic glutamate receptors. Bioorganic & Medicinal Chemistry Letters. 8(14). 1919–1922. 32 indexed citations
7.
8.
Zarrinmayeh, Hamideh, Paul L. Ornstein, Dennis M. Zimmerman, et al.. (1998). Synthesis and Evaluation of a Series of Novel 2-[(4-Chlorophenoxy)methyl]- benzimidazoles as Selective Neuropeptide Y Y1 Receptor Antagonists. Journal of Medicinal Chemistry. 41(15). 2709–2719. 134 indexed citations
9.
10.
11.
Behforouz, Mohammad, et al.. (1996). Highly Efficient and Practical Syntheses of Lavendamycin Methyl Ester and Related Novel Quinolindiones. The Journal of Organic Chemistry. 61(19). 6552–6555. 39 indexed citations
12.
13.
Ornstein, Paul L., M. Brian Arnold, J. David Leander, et al.. (1995). (3SR,4aRS,6SR,8aRS)-6-(1H-Tetrazol-5-yl)decahydroisoquinoline-3-carboxylic Acid, a Novel, Competitive, Systemically Active NMDA and AMPA Receptor Antagonist. Journal of Medicinal Chemistry. 38(25). 4885–4890. 16 indexed citations
14.
15.
Ornstein, Paul L., et al.. (1993). Tetrazole amino acids as competitive NMDA antagonists. Bioorganic & Medicinal Chemistry Letters. 3(1). 43–48. 18 indexed citations
16.
Ornstein, Paul L., M. Brian Arnold, Jack B. Deeter, et al.. (1993). Unusual stereochemical preferences of decahydroisoquinoline-3-cargoxylic acid competitive NMDA antagonists. Bioorganic & Medicinal Chemistry Letters. 3(10). 2067–2072. 9 indexed citations
17.
Ornstein, Paul L., Darryle D. Schoepp, M. Brian Arnold, et al.. (1992). 6-Substituted decahydroisoquinoline-3-carboxylic acids as potent and selective conformationally constrained NMDA receptor antagonists. Journal of Medicinal Chemistry. 35(19). 3547–3560. 25 indexed citations
18.
Ornstein, Paul L., Darryle D. Schoepp, M. Brian Arnold, et al.. (1992). NMDA antagonist activity of (.+-.)-(2SR,4RS)-4-(1H-tetrazol-5-ylmethyl)piperidine-2-carboxylic acid residues with the (-)-2R,4S-isomer. Journal of Medicinal Chemistry. 35(17). 3111–3115. 17 indexed citations
19.
Ornstein, Paul L., D D Schoepp, M. Brian Arnold, et al.. (1991). 4-(Tetrazolylalkyl)piperidine-2-carboxylic acids. Potent and selective N-methyl-D-aspartic acid receptor antagonists with a short duration of action. Journal of Medicinal Chemistry. 34(1). 90–97. 76 indexed citations
20.
Ornstein, Paul L., et al.. (1991). Syntheses of 6-oxodecahydroisoquinoline-3-carboxylates. Useful intermediates for the preparation of conformationally defined excitatory amino acid antagonists. The Journal of Organic Chemistry. 56(14). 4388–4392. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric Vieira Breakdown of academic impact, for papers by Günter Neef Breakdown of academic impact, for papers by David D. Wisnoski Breakdown of academic impact, for papers by Fabrizio Micheli Breakdown of academic impact, for papers by Andrew Thurkauf Breakdown of academic impact, for papers by B. L. CHENARD Breakdown of academic impact, for papers by Kevin J. Merchant Breakdown of academic impact, for papers by Romano Di Fabio Breakdown of academic impact, for papers by Edwin J. Schweiger Breakdown of academic impact, for papers by Dianne Kowal
Rankless by CCL
2026